학술논문
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer
Document Type
Article
Author
Source
In Annals of Oncology June 2010 21(6):1302-1307
Subject
Language
ISSN
0923-7534